Alcon Shareholders Can't Keep Merger Suit In US

Plaintiffs in a shareholder lawsuit accusing Novartis AG of shortchanging them in its $28.1 billion merger with eye care company Alcon Inc. have lost a bid for reconsideration of the court's...

Already a subscriber? Click here to view full article